SCHEMBL12419583

SCHEMBL12419583

OB(O)c1ccc(-c2nnc(-c3ccccc3)o2)c(Cl)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 15/20 0.67
NPC1 O15118 14/20 0.67
SMN1; SMN2 Q16637 11/20 0.67
ALDH1A1 P00352 7/20 0.67
HPGD P15428 6/20 0.67
TP53 P04637 5/20 0.67
TSHR P16473 4/20 0.67
HSD17B10 Q99714 2/20 0.67
NPSR1 Q6W5P4 1/20 0.67
KDM4E B2RXH2 6/20 0.50
CA1 P00915 4/20 0.50
CA2 P00918 4/20 0.50
NFKB1 P19838 4/20 0.50
NFKB2 Q00653 4/20 0.50
RELA Q04206 4/20 0.50
CA9 Q16790 3/20 0.50
CA13 Q8N1Q1 2/20 0.50
CA12 O43570 1/20 0.50
CASP3 P42574 1/20 0.50
SENP8 Q96LD8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12419582 0.83 RAB9A (0.49) RAB9ANPC1SMN1; SMN2ALDH1A1HPGD
SCHEMBL11484481 0.80 NPC1 (1.00) RAB9ANPC1SMN1; SMN2ALDH1A1HPGD
SCHEMBL30611004 0.80 NPC1 (1.00) RAB9ANPC1SMN1; SMN2ALDH1A1HPGD
SCHEMBL2816834 0.80 NPC1 (0.65) RAB9ANPC1SMN1; SMN2ALDH1A1HPGD
SCHEMBL30484413 0.80 CA1 (0.52) CA1CA2
SCHEMBL12419603 0.80 ALDH1A1 (0.45) RAB9ANPC1SMN1; SMN2ALDH1A1HPGD
SCHEMBL12419461 0.79 MGLL (0.61) RAB9ANPC1SMN1; SMN2ALDH1A1HPGD
SCHEMBL19649005 0.76 RAB9A (0.81) RAB9ANPC1SMN1; SMN2ALDH1A1HPGD
SCHEMBL12419458 0.72 RAB9A (0.62) RAB9ANPC1SMN1; SMN2ALDH1A1HPGD
SCHEMBL11479736 0.72 NPC1 (0.63) RAB9ANPC1SMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2015-12-24 US disclosed
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2015-12-24 US disclosed
US-8957049-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2015-02-17 US disclosed
US-8957049-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2015-02-17 US disclosed
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. 2011-07-14 US disclosed
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. 2011-07-14 US disclosed
WO-2009126691-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC (US) 2009-10-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 RAB9A 1820/4885NPC1 472/4885SMN1; SMN2 3053/4885
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 RAB9A 1820/4885NPC1 472/4885SMN1; SMN2 3053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.